Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Opsens Inc. (T:OPS)

Business Focus: Advanced Medical Equipment & Technology (NEC)

INK Edge Outlook

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for OPS within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Dec 01, 2022 15:56 ET
OPSENS INC. ANNOUNCES $10 MILLION BOUGHT DEAL OFFERING
/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Read full article
Nov 29, 2022 06:00 ET
OPSENS ANNOUNCES FIRST SAVVYWIRE™ PROCEDURE IN NEW ZEALAND
QUEBEC CITY, Nov. 29, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that Dr. Sanjeevan Pasupati, Director of Structural Heart Disease & Cardiovascular Research at Waikato Hospital in Hamilton, New Zealand and his team, performed the first transcatheter aortic valve replacement (TAVR) procedures using SavvyWire in New Zealand.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.55
--
--
Price to Sales - TTM
5.98
6.95
4.47
Price to Book - most recent quarter
6.16
2.93
1.67
Price to Cash Flow per share - TTM
--
27.71
9.11
Price to Free Cash Flow per share - TTM
--
2.14
12.54
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 30, 202276,433-87,651
Nov 15, 2022164,084-183,822
Oct 31, 2022347,906-70,905
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

OpSens Inc. is a medical device cardiology-focused company. The Company operates through two segments: Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.

See business summary

 

Twitter

Search (past week) for $OPS.CA

  • No tweets found